Dr Zilu wang
Honorary (Fellow)
Department of Medical Biology (WEHI)
10 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma
DOI: 10.1038/s41467-025-62615-y2024
Journal article
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
DOI: 10.1158/2159-8290.CD-23-04022024
Journal article
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses
DOI: 10.1038/s41418-023-01249-32023
Journal article
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells
DOI: 10.1038/s41418-023-01122-32023
Journal article
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs
DOI: 10.1038/s41418-023-01117-02023
Journal article
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Cell Death & Differentiation, (2023), 30, 4, (1033-1046), 10.1038/s41418-023-01122-3)
DOI: 10.1038/s41418-023-01137-w2022
Journal article
BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells
DOI: 10.1038/s41418-022-00977-2
RECENT SCHOLARLY WORKS
2022
Journal article
Loss of TRP53 reduces but does not overcome dependency of lymphoma cells on MCL-1
DOI: 10.1038/s41418-022-00946-92022
Journal article
Should mutant TP53 be targeted for cancer therapy?
DOI: 10.1038/s41418-022-00962-92022
Journal article
Flow cytometric single cell-based assay to simultaneously detect cell death, cell cycling, DNA content and cell senescence
DOI: 10.1038/s41418-022-00964-7